[go: up one dir, main page]

WO2012147107A3 - Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition - Google Patents

Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition Download PDF

Info

Publication number
WO2012147107A3
WO2012147107A3 PCT/IN2012/000314 IN2012000314W WO2012147107A3 WO 2012147107 A3 WO2012147107 A3 WO 2012147107A3 IN 2012000314 W IN2012000314 W IN 2012000314W WO 2012147107 A3 WO2012147107 A3 WO 2012147107A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
novel
improved processes
indoline derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2012/000314
Other languages
French (fr)
Other versions
WO2012147107A2 (en
Inventor
Srinivasan Thirumalai Rajan
Sajja Eswaraiah
Mummadi Venkatesh
Elevathingal Nicholas Madhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSN Laboratories Pvt Ltd
Original Assignee
MSN Laboratories Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MSN Laboratories Pvt Ltd filed Critical MSN Laboratories Pvt Ltd
Publication of WO2012147107A2 publication Critical patent/WO2012147107A2/en
Publication of WO2012147107A3 publication Critical patent/WO2012147107A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Disclosed are processes for the preparation of 1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl} amino)propyl] -2,3-dihydro-lH-indole-7-carboxamide compound represented by the following structural formula-1 and it's pharmaceutical composition. (I)
PCT/IN2012/000314 2011-04-29 2012-04-27 Novel & improved processes for the preparation of indoline derivatives and its pharmaceutical composition Ceased WO2012147107A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IN1480/CHE/2011 2011-04-29
IN1480CH2011 2011-04-29
IN588CH2012 2012-02-17
IN588/CHE/2012 2012-02-17
IN1628/CHE/2012 2012-04-25
IN1628CH2012 2012-04-25

Publications (2)

Publication Number Publication Date
WO2012147107A2 WO2012147107A2 (en) 2012-11-01
WO2012147107A3 true WO2012147107A3 (en) 2012-12-20

Family

ID=47072838

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2012/000314 Ceased WO2012147107A2 (en) 2011-04-29 2012-04-27 Novel & improved processes for the preparation of indoline derivatives and its pharmaceutical composition

Country Status (1)

Country Link
WO (1) WO2012147107A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140243383A1 (en) * 2011-08-24 2014-08-28 Cadila Healthcare Limited Pharmaceutical compositions of silodosin
CA2907977A1 (en) 2013-04-09 2014-10-16 Mankind Research Centre N-haloalkylindoline intermediates, their process and use in preparation of silodosin and its derivatives
CN103265470B (en) * 2013-05-29 2015-10-28 华润赛科药业有限责任公司 A kind of synthetic method of silodosin dialkylate
CN105636440A (en) 2013-10-17 2016-06-01 美国陶氏益农公司 Processes for the preparation of pesticidal compounds
JP6487426B2 (en) 2013-10-17 2019-03-20 ダウ アグロサイエンシィズ エルエルシー Process for the preparation of pest control compounds
CA2926095A1 (en) 2013-10-17 2015-04-23 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
JP2016536295A (en) * 2013-10-17 2016-11-24 ダウ アグロサイエンシィズ エルエルシー Method for producing pest control compound
CN105636446B (en) 2013-10-17 2018-07-13 美国陶氏益农公司 The method for preparing Pesticidal compound
MX2016004942A (en) 2013-10-17 2016-06-28 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds.
EP3057431A4 (en) 2013-10-17 2017-04-05 Dow AgroSciences LLC Processes for the preparation of pesticidal compounds
KR101725393B1 (en) * 2014-07-24 2017-04-27 주식회사 경보제약 Manufacturing method for Silodosin and new intermediate thereof
CA2954345A1 (en) 2014-07-31 2016-02-04 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
EP3186230A4 (en) 2014-07-31 2018-01-10 Dow AgroSciences, LLC Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
BR112017000418A2 (en) 2014-07-31 2017-11-07 Dow Agrosciences Llc Process for the preparation of 3- (3-chloro-1h-pyrazol-1-yl) pyridine
EP3183238A4 (en) 2014-08-19 2018-01-10 Dow AgroSciences LLC Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
BR112017004613A2 (en) 2014-09-12 2017-12-05 Dow Agrosciences Llc Process for the preparation of 3- (3-chloro-1h-pyrazol-1-yl) pyridine
WO2016042441A1 (en) 2014-09-18 2016-03-24 Mankind Research Centre A novel process for the preparation of considerably pure silodosin
JP2016088847A (en) * 2014-10-30 2016-05-23 株式会社トクヤマ (-)-1- (3-hydroxypropyl) -5-[[(2R) -2-({2- [2- (2,2,2-trifluoroethoxy) phenoxy] ethyl} amino) propyl]- 2,3-Dihydro-1H-indole-7-carboxamide])
CN104557662B (en) * 2014-12-26 2017-01-25 华润赛科药业有限责任公司 Synthesis method of silodosin dialkyl compound
US9356405B1 (en) 2015-03-05 2016-05-31 Sony Corporation Connector tongue element for an electrical connector plug receptacle and a method for producing the same
ES2607639B1 (en) 2015-09-30 2018-02-28 Urquima, S.A Maleic acid salt of a silodosin intermediate
JP2018080125A (en) * 2016-11-15 2018-05-24 宇部興産株式会社 METHOD FOR PRODUCING β CRYSTALS OF INDOLINE COMPOUNDS
US10100033B2 (en) 2016-12-29 2018-10-16 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
WO2018125817A1 (en) 2016-12-29 2018-07-05 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
EP3354283B1 (en) 2017-06-20 2019-08-07 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical capsule composition comprising silodosin

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387603A (en) * 1992-12-02 1995-02-07 Kissei Pharmaceutical Co., Ltd. 1,5,7-trisubstituted indoline compounds and salts thereof
JP2002265444A (en) * 2001-03-08 2002-09-18 Kissei Pharmaceut Co Ltd 1-(3-benzyloxypropyl)-5-(2-substituted propyl) indoline derivative and method for using the same
JP2006188470A (en) * 2005-01-07 2006-07-20 Kissei Pharmaceut Co Ltd Indoline derivative and method for producing the same
CN101048376A (en) * 2004-10-27 2007-10-03 橘生药品工业株式会社 Indoline compound and process for producing the same
CN101993407A (en) * 2009-08-27 2011-03-30 浙江华海药业股份有限公司 Indoline compound for preparing silodosin and preparation method thereof
CN101993405A (en) * 2009-08-27 2011-03-30 浙江华海药业股份有限公司 Indoline derivative as well as preparation method and application thereof
WO2011124704A1 (en) * 2010-04-09 2011-10-13 Ratiopharm Gmbh Process for preparing an intermediate for silodosin
WO2012014186A1 (en) * 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Process for the preparation of silodosin and its novel intermediates

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387603A (en) * 1992-12-02 1995-02-07 Kissei Pharmaceutical Co., Ltd. 1,5,7-trisubstituted indoline compounds and salts thereof
JP2002265444A (en) * 2001-03-08 2002-09-18 Kissei Pharmaceut Co Ltd 1-(3-benzyloxypropyl)-5-(2-substituted propyl) indoline derivative and method for using the same
CN101048376A (en) * 2004-10-27 2007-10-03 橘生药品工业株式会社 Indoline compound and process for producing the same
JP2006188470A (en) * 2005-01-07 2006-07-20 Kissei Pharmaceut Co Ltd Indoline derivative and method for producing the same
CN101993407A (en) * 2009-08-27 2011-03-30 浙江华海药业股份有限公司 Indoline compound for preparing silodosin and preparation method thereof
CN101993405A (en) * 2009-08-27 2011-03-30 浙江华海药业股份有限公司 Indoline derivative as well as preparation method and application thereof
WO2011124704A1 (en) * 2010-04-09 2011-10-13 Ratiopharm Gmbh Process for preparing an intermediate for silodosin
WO2012014186A1 (en) * 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Process for the preparation of silodosin and its novel intermediates

Also Published As

Publication number Publication date
WO2012147107A2 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
WO2012147107A3 (en) Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition
WO2013052550A3 (en) Novel imidazole quinoline-based immune system modulators
IL212435A (en) Isoindoline compounds, pharmaceutical compositions comprising the same and use thereof for the preparation of medicaments
WO2010065709A3 (en) Hydroxamic acid derivatives, preparation and therapeutic uses thereof
NZ600801A (en) Substituted imidazopyridinyl-aminopyridine compounds
HK1203412A1 (en) Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
EP4219465A3 (en) Prmt5 inhibitors and uses thereof
WO2009085990A3 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
EP4268814A3 (en) Pharmaceutical composition for the treatment of dry eye
CA2725933A1 (en) Drug combinations comprising a dgat inhibitor and a ppar-agonist
BRPI0910758A2 (en) thermostable solid composition, pharmaceutical composition, processes for preparing a thermostable solid composition and a pharmaceutical composition, method for improving the bioavailability of a pharmaceutically active ingredient, and
WO2009140341A3 (en) Atorvastatin compositions
WO2010049449A3 (en) Novel salts of sunitinib
MX344109B (en) Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazo l-2-yl)-1h-pyrazole-4-carboxylic acid.
EA201200616A1 (en) DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL
IL230487B (en) 6-(n-(7-chloro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5- yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-n-methylbenzofuran-3-carboxamide compounds, pharmaceutically acceptable salts thereof and pharmaceutical composition comprising them
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
GEP20135805B (en) 1-(ARYLSULFONYL)-4-(PIPERAZIN-1-YL)-1H-BENZIMIDAZOLES AS δ-HYDROXYTRYPTAMINE-6 LIGANDS
WO2013169746A3 (en) N-ethyl-4-hydroxyl-1-methyl-5- (methyl(2,3,4,5,6-pentahydroxyhexyl) amino) -2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide
IN2012DN04868A (en)
PT2231598E (en) Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
BR112013007904A2 (en) "compound, pharmaceutical composition, drug, use of a compound and process for preparing a compound"
WO2011042890A3 (en) Use of phenolic compounds for protein deglycolysation
WO2010131192A3 (en) Novel oxazolidinone derivatives and their use as orexin receptor antagonists
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12776781

Country of ref document: EP

Kind code of ref document: A2